This smallcap healthcare stock extends rise as analysts see strong growth
The analysts at the brokerage maintained its 'Overweight' rating on the stock and recommended it as a long-term investment.
The analysts at the brokerage maintained its 'Overweight' rating on the stock and recommended it as a long-term investment.
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
